Immediate Impact

1 by Nobel laureates 1 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
5 intermediate papers

Works of Joyce Varughese being referenced

High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
2011
Uterine serous papillary carcinomas overexpress human trophoblast‐cell‐surface marker (trop‐2) and are highly sensitive to immunotherapy with hRS7, a humanized anti‐trop‐2 monoclonal antibody
2011
and 3 more

Author Peers

Author Last Decade Papers Cites
Joyce Varughese 116 320 40 200 21 610
Ilaria Betella 104 318 6 184 25 566
Diana P. English 208 264 32 177 31 652
A P Kudelka 135 167 6 183 24 587
A. Bamias 64 222 6 204 27 549
Y Decroix 124 189 9 161 19 659
Amnon Amit 118 399 234 30 722
Linda J. Paradiso 91 244 12 192 20 688
Raquel Bratos 211 314 1 111 13 581
Mignon-Denise Keyver-Paik 96 249 2 80 30 536
Aliki Taylor 43 377 4 131 17 602

All Works

Loading papers...

Rankless by CCL
2026